Matrix Pharmaceutical (MATX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matrix Pharmaceutical (MATX)

MATX 142.51

+8.0%

12:53 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: J.F.K. who wrote (188)	10/10/1998 8:32:00 PM
From: tnsaf	Read Replies (2) of 240

Let's add a little life to the thread, eh? Jason biz.yahoo.com Wednesday September 23, 8:08 am Eastern Time Company Press Release Matrix Pharmaceutical Licenses Anticancer Agent Ready for Phase II Clinical Trials from Hoechst Marion Roussel biz.yahoo.com Thursday October 1, 8:00 am Eastern Time Company Press Release Matrix Pharmaceutical Reports Clinical Results of Intradose Injectable Gel in Advanced Breast Cancer 47% Tumor Response Rate in Most Troublesome Tumors Reported

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next